In contrast, an earlier study documented that elevated BMX expression in aggressive cancers such as prostate, breast, and colon cancers is linked to heightened apoptosis resistance and poorer patient survival outcomes [1], indicating that the role of BMX in cancer may be complex and context-dependent. This evidence concerns the gene BMX and cancer.